Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
BSX
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Why Boston Scientific (BSX) Outpaced the Stock Market Today
Boston Scientific (BSX) ended the recent trading session at $42.73, demonstrating a +1.64% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.6%. On the other hand, the Dow reg…
Gold Reserve Files Response in Citgo Appeal, Supporting Venezuela’s Request for Abeyance, Subject to Support of the United States
PEMBROKE, Bermuda, October 09, 2026--(BUSINESS WIRE)--Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) ("Gold Reserve" or the "Company") announces that it has filed a Response to Venezuela's motion for an abeyance of the appeal…
Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors
Boston Scientific (BSX) closed the most recent trading day at $42.04, moving +1.11% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 0.47% for the day. At the same time, the Dow added 0.1%, and…
Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know
Boston Scientific (BSX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this…
1 Safe-and-Steady Stock to Research Further and 2 Facing Challenges
1 Safe-and-Steady Stock to Research Further and 2 Facing Challenges Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Finding the righ…
Citi reiterates these 2 medtech stocks as its top picks in the sector
Investing.com-- Citi reiterated its top picks in the medtech sector, highlighting Abbott Laboratories and Dexcom as standout opportunities while pointing to diverging fortunes across the industry. Before you buy NVIDIA: our AI model's stoc…
Why Is Boston Scientific (BSX) Reorganizing Into Three Segments Under A New COO?
Boston Scientific (NYSE: BSX) appointed Joseph M. Fitzgerald as executive vice president and chief operating officer, effective January 1, 2027. The company plans to reorganize its global operations into three reportable segments: Interven…
Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
New operating structure designed to increase efficiency and support continued growth MARLBOROUGH, Mass., Oct. 7, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Joseph M. Fitzgerald to exec…
Stryker (SYK) vs Boston Scientific (BSX): Which is a Better Stock to Buy?
Stryker Corporation (NYSE:SYK) traded at around $280 on October 6, 22.75% lower over twelve months. Boston Scientific Corporation (NYSE:BSX) traded near $42 over the same session, down 55.79% across the year and within sixty cents of its 5…
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of J&J's total revenues. In MedTech, J&J is a gl…
2 Cash-Producing Stocks Worth Investigating and 1 That Underwhelm
2 Cash-Producing Stocks Worth Investigating and 1 That Underwhelm Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leadin…
Moderna, Illumina lead healthcare gains in September as medtech drags
[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV]) f…
Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know
Boston Scientific (BSX) closed at $42.60 in the latest trading session, marking a -1.46% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.73% for the day. Elsewhere, the Dow gained 0.49%, while the…
Can ISRG Offset China Weakness With Expansion in India and Japan?
Intuitive Surgical's ISRG geographical growth story is becoming increasingly diversified, with strong momentum in India and improving conditions in Japan helping counterbalance challenges in China. In the second quarter, international da V…
2 Oversold Stocks Primed to Rebound and 1 We Find Risky
2 Oversold Stocks Primed to Rebound and 1 We Find Risky The past year hasn't been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether they're witnessing fire s…
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
Elutia Inc. Boston Scientific released the full $8 million holdback on schedule and with no claims Escrow release is the third funding catalyst Elutia has delivered in 2026, following the August closings of its Avenue Capital loan facility…
2 Profitable Stocks to Research Further and 1 We Avoid
2 Profitable Stocks to Research Further and 1 We Avoid Even if a company is profitable, it doesn't always mean it's a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their futu…
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects
Boston Scientific's BSX MedSurg segment continues to provide a diversified and stable revenue base. Within this, Endoscopy sales grew 7% year over year in the second quarter of 2026, driven by strong performance across the business and ano…
Cyted Health appoints Thomas West as Board Chair and Robert Epstein as Non-Executive Director to drive US growth
CAMBRIDGE, England and WILMINGTON, Del., Sept. 29, 2026 /PRNewswire/ -- Cyted Health, a leading gastrointestinal molecular diagnostics company, today announced the appointment of Thomas West as Chair of its Board of Directors and Non-Execu…
Cyted Health appoints Thomas West as Board Chair and Robert Epstein as Non-Executive Director to drive US growth
CAMBRIDGE, England and WILMINGTON, Del., Sept. 29, 2026 /PRNewswire/ -- Cyted Health, a leading gastrointestinal molecular diagnostics company, today announced the appointment of Thomas West as Chair of its Board of Directors and Non-Execu…
Boston Scientific wins up to $135.7M U.S. defense health contract
[Boston Scientific office building in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images * Boston Scientific (BSX [https://seekingalpha.com/symbol/BSX]) won a maximum $135.7M IDIQ contract for cardiovascular procedural pa…
Could Boston Scientific’s $300 Million Cyber Hit Be Mostly a 2026 Problem?
Wells Fargo has put a number on the damage Boston Scientific Corporation's (NYSE:BSX) August cybersecurity incident could do to its third-quarter results, which comes up to roughly $300 million in sales and about $0.13 per share in earning…
Why Oppenheimer Cut Boston Scientific’s Price Target by $20 Despite Keeping its Outperform Rating
Oppenheimer has become considerably more cautious on Boston Scientific Corporation (NYSE:BSX), but not cautious enough to abandon its bullish rating. Analyst Suraj Kalia lowered the firm's price target on Boston Scientific to $65 from $85…
Boston Scientific (BSX) Faces A Recall, Is The 28% Undervaluation Still Compelling?
Boston Scientific (BSX) is in focus after initiating a Class II recall of its StoneSmart Connect Console power adapters, affecting 982 units distributed across the US and multiple international markets. Against this recall backdrop, Boston…
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect…
What Do Boston Scientific (BSX) Recall And Executive Retirement Mean For Investors?
Boston Scientific (NYSE: BSX) has started a voluntary global recall of its StoneSmart Connect Console over a power adapter safety issue. The company is informing hospitals and healthcare providers worldwide about the recall and advising on…
Global Remote Cardiac Monitoring Market Size, Share & Trends Analysis 2026-2036 Featuring Profiles of Medtronic, Abbott Labs, Boston Scientific, GE HealthCare Technologies, Philips, Baxter International (Hillrom) and Other Key Players
Company Logo Growth is driven by rising cardiovascular disease, telehealth adoption, and advances in wearable ECG devices, implantable monitors, AI analytics, and cloud platforms. North America leads, while Asia-Pacific is expected to grow…
Boston Scientific (BSX) Stock Moves 2.74%: What You Should Know
In the latest close session, Boston Scientific (BSX) was up +2.74% at $44.92. At the same time, the Dow lost 0.36%, and the tech-heavy Nasdaq gained 0.45%. The medical device manufacturer's shares have seen a decrease of 10.79% over the la…
Top Analyst Reports for NVIDIA, Berkshire Hathaway & GE Aerospace
Tuesday, September 22, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Berkshire Hathaway Inc. (BR…
How Far Can BSX Stock Swing After Losing More Than Half Its Value?
Image from Unsplash Boston Scientific (BSX) stock has fallen 55.5% over the past twelve months, and at $43.72 it trades barely above its 52-week low of $42.63. The options market now prices a likely one-year range from $28.46 to $67.16 a s…
Ammonix Launches a New AI Architecture for High-Stakes Specialist Agents That Outperform Frontier Models at a Lower Cost
BLONAY, Switzerland and WILMINGTON, Del., Sept. 22, 2026 /PRNewswire/ -- Ammonix today emerged from stealth with a new AI architecture that combines a fast, specialized System One decision-making architecture with a System Two language mod…
Ammonix Launches a New AI Architecture for High-Stakes Specialist Agents That Outperform Frontier Models at a Lower Cost
BLONAY, Switzerland and WILMINGTON, Del., Sept. 22, 2026 /PRNewswire/ -- Ammonix today emerged from stealth with a new AI architecture that combines a fast, specialized System One decision-making architecture with a System Two language mod…
2 Value Stocks with Exciting Potential and 1 We Avoid
2 Value Stocks with Exciting Potential and 1 We Avoid Value investing has produced some of the world's most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wo…
Will Boston Scientific's Upcoming Launches Fuel the Next Growth Phase?
Boston Scientific BSX is preparing for a steady stream of product launches over the next two years that could become an important source of incremental growth. In Interventional Cardiology, the company plans to launch the SEISMIQ 4CE Coron…
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: AGCO Corporation AGCO is an agricultural equipment manufacturing company. The Zacks Consensus Estimate for its current year earnings has been revised 9.3% downward…
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Travis Hoium discuss: GE Aerospace acquires Consolidated Precision Products. The winners and losers of the deal. Boston Scientifi…